Symbols / NMTC Stock $3.72 +4.79% NeuroOne Medical Technologies Corporation

Healthcare • Medical Devices • United States • NCM
NMTC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. David A. Rosa M.D.
Exch · Country NCM · United States
Market Cap 32.07M
Enterprise Value 29.47M
Income -6.64M
Sales 12.72M
FCF (ttm) -5.36M
Book/sh 0.62
Cash/sh 0.33
Employees 18
Insider 10d —
IPO Mar 15, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -13.29
PEG —
P/S 2.52
P/B 5.96
P/C —
EV/EBITDA -4.33
EV/Sales 2.32
Quick Ratio 3.10
Current Ratio 4.38
Debt/Eq 3.85
LT Debt/Eq —
EPS (ttm) -0.89
EPS next Y -0.28
EPS Growth —
Revenue Growth 72.50%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-13
Earnings (prior) 2026-02-17
ROA -71.68%
ROE -204.44%
ROIC —
Gross Margin 24.68%
Oper. Margin -87.86%
Profit Margin -52.23%
Shs Outstand 8.62M
Shs Float 7.84M
Insider Own 15.27%
Instit Own 22.77%
Short Float 0.54%
Short Ratio 0.94
Short Interest 45.30K
52W High 6.96
vs 52W High -46.55%
52W Low 3.28
vs 52W Low 13.55%
Beta 0.58
Impl. Vol. 50.00%
Rel Volume 0.76
Avg Volume 39.77K
Volume 30.19K
Target (mean) $9.93
Tgt Median $8.80
Tgt Low $8.00
Tgt High $13.00
# Analysts 3
Recom None
Prev Close $3.55
Price $3.72
Change 4.79%
About

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.93
Mean price target
2. Current target
$3.72
Latest analyst target
3. DCF / Fair value
$-11.19
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.72
Low
$8.00
High
$13.00
Mean
$9.93

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-13 main Ladenburg Thalmann Buy → Buy $8
2026-03-02 init Jones Trading — → Buy $2
2025-09-09 init Maxim Group — → Buy $3
2025-05-05 init Ladenburg Thalmann — → Buy $1
2023-08-15 main Alliance Global Partners Buy → Buy $2
2022-03-28 down Craig-Hallum Buy → Hold —
2021-12-03 init Alliance Global Partners — → Buy $6
2021-11-15 init Craig-Hallum — → Buy $6
News
RSS: Latest NMTC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2020-06-15 MATHIESEN JEFFREY S Director — 34,020 $0.04 $1,191
2020-06-12 CHRISTIANSON MARK Officer — 334,000 $1.57 $524,380
2020-06-02 MATHIESEN JEFFREY S Director — 22,371 $0.00 $0
2020-06-02 BUCKMAN PAUL R Director — 22,371 $0.00 $0
2020-06-02 ANDRLE EDWARD Director — 22,371 $0.00 $0
2020-02-19 ANDRLE EDWARD Director — 7,064 $0.00 $0
2020-02-10 MATHIESEN JEFFREY S Director — 26,261 $0.00 $0
2020-02-10 BUCKMAN PAUL R Director — 44,118 $0.00 $0
2019-06-04 MATHIESEN JEFFREY S Director — 14,006 $0.00 $0
2019-06-04 BUCKMAN PAUL R Director — 14,006 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Revenue
9.10
+163.47%
3.45
+76.86%
1.95
+1040.65%
0.17
Operating Revenue
9.10
+163.47%
3.45
+76.86%
1.95
+1040.65%
0.17
Cost Of Revenue
3.96
+66.70%
2.37
+58.65%
1.50
+518.24%
0.24
Reconciled Cost Of Revenue
3.96
+66.70%
2.37
+58.65%
1.50
+518.24%
0.24
Gross Profit
5.14
+376.20%
1.08
+136.50%
0.46
+744.85%
-0.07
Operating Expense
9.37
-27.76%
12.97
+4.47%
12.41
+24.62%
9.96
Research And Development
4.98
-1.62%
5.07
-27.02%
6.94
+40.80%
4.93
Selling General And Administration
7.38
-6.55%
7.90
+14.08%
6.93
-0.76%
6.98
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Other Operating Expenses
-3.00
—
-1.46
+25.33%
-1.95
Total Expenses
13.32
-13.14%
15.34
+10.30%
13.91
+36.32%
10.20
Operating Income
-4.23
+64.45%
-11.89
+0.57%
-11.96
-19.19%
-10.03
Total Operating Income As Reported
-4.23
+64.45%
-11.89
+0.57%
-11.96
-19.19%
-10.03
EBITDA
-3.01
+74.59%
-11.84
-1.56%
-11.66
-17.64%
-9.91
Normalized EBITDA
-3.79
+67.05%
-11.52
+1.24%
-11.66
-17.64%
-9.91
Reconciled Depreciation
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
EBIT
-3.27
+72.94%
-12.09
-1.94%
-11.86
-18.23%
-10.03
Total Unusual Items
0.78
+339.89%
-0.33
—
—
Total Unusual Items Excluding Goodwill
0.78
+339.89%
-0.33
—
—
Special Income Charges
—
—
—
—
Net Income
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Pretax Income
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Non Operating Interest Income Expense
-0.33
-45.89%
-0.23
0.00
0.00
Interest Expense Non Operating
0.33
+45.89%
0.23
0.00
0.00
Net Interest Income
-0.33
-45.89%
-0.23
0.00
0.00
Interest Expense
0.33
+45.89%
0.23
0.00
0.00
Other Income Expense
0.96
+573.06%
-0.20
-310.86%
0.10
+207.39%
0.03
Other Non Operating Income Expenses
0.17
+36.20%
0.13
+30.72%
0.10
+207.39%
0.03
Gain On Sale Of Security
0.78
+339.89%
-0.33
—
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income From Continuing Operation Net Minority Interest
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income From Continuing And Discontinued Operation
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Net Income Continuous Operations
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Normalized Income
-4.39
+63.39%
-11.99
-1.11%
-11.86
-18.60%
-10.00
Net Income Common Stockholders
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Diluted EPS
-0.54
+80.43%
-2.76
+29.23%
-3.90
-3.17%
-3.78
Basic EPS
-0.54
+80.43%
-2.76
+29.23%
-3.90
-3.17%
-3.78
Basic Average Shares
6.69
+50.03%
4.46
+47.69%
3.02
+13.27%
2.67
Diluted Average Shares
6.69
+50.03%
4.46
+47.69%
3.02
+13.27%
2.67
Diluted NI Availto Com Stockholders
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total Assets
10.79
+100.85%
5.37
-33.68%
8.10
-36.85%
12.82
Current Assets
10.23
+120.83%
4.63
-36.67%
7.31
-39.94%
12.18
Cash Cash Equivalents And Short Term Investments
6.57
+350.01%
1.46
-72.57%
5.32
-52.23%
11.14
Cash And Cash Equivalents
6.57
+350.01%
1.46
-72.57%
5.32
-34.78%
8.16
Cash Financial
—
—
—
—
Other Short Term Investments
—
—
0.00
-100.00%
2.98
Receivables
1.26
+616.05%
0.18
0.00
-100.00%
0.03
Accounts Receivable
1.26
+616.05%
0.18
0.00
-100.00%
0.03
Inventory
2.23
-15.50%
2.64
+52.61%
1.73
+145.08%
0.70
Work In Process
0.13
-32.37%
0.19
-44.02%
0.34
+49.06%
0.23
Finished Goods
1.23
-21.75%
1.57
+768.35%
0.18
+143.77%
0.07
Prepaid Assets
0.14
-34.69%
0.22
-17.93%
0.26
-11.09%
0.30
Current Deferred Assets
0.02
-83.93%
0.14
0.00
0.00
Total Non Current Assets
0.56
-24.31%
0.74
-5.78%
0.78
+21.26%
0.65
Net PPE
0.51
-23.42%
0.67
-3.32%
0.69
+29.88%
0.53
Gross PPE
1.31
+6.66%
1.23
+19.56%
1.03
+42.77%
0.72
Accumulated Depreciation
-0.80
-42.78%
-0.56
-67.01%
-0.33
-79.75%
-0.19
Machinery Furniture Equipment
1.06
+8.37%
0.98
+13.43%
0.86
+45321.48%
0.00
Other Properties
0.26
+0.11%
0.25
+50.78%
0.17
-76.50%
0.72
Goodwill And Other Intangible Assets
0.04
-33.18%
0.07
-24.91%
0.09
-19.94%
0.11
Total Liabilities Net Minority Interest
3.71
-18.36%
4.55
+146.11%
1.85
-42.58%
3.22
Current Liabilities
2.30
+4.06%
2.21
+23.46%
1.79
-42.15%
3.10
Payables And Accrued Expenses
2.18
+4.33%
2.09
+25.49%
1.66
+6.62%
1.56
Payables
1.01
-1.83%
1.03
+50.23%
0.69
-26.15%
0.93
Accounts Payable
1.01
-1.83%
1.03
+50.23%
0.69
-26.15%
0.93
Current Accrued Expenses
1.17
+10.33%
1.06
+8.17%
0.98
+54.69%
0.63
Current Debt And Capital Lease Obligation
0.12
+88.02%
0.07
-49.06%
0.13
+54.93%
0.08
Current Capital Lease Obligation
0.12
+88.02%
0.07
-49.06%
0.13
+54.93%
0.08
Current Deferred Liabilities
—
—
0.00
-100.00%
1.46
Current Deferred Revenue
—
—
0.00
-100.00%
1.46
Other Current Liabilities
0.00
-97.61%
0.06
—
—
Total Non Current Liabilities Net Minority Interest
1.41
-39.61%
2.33
+4123.12%
0.06
-53.76%
0.12
Long Term Debt And Capital Lease Obligation
0.14
-26.36%
0.19
+251.62%
0.06
-53.76%
0.12
Long Term Capital Lease Obligation
0.14
-26.36%
0.19
+251.62%
0.06
-53.76%
0.12
Stockholders Equity
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Common Stock Equity
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Capital Stock
0.05
+62.27%
0.03
+28.78%
0.02
+47.56%
0.02
Common Stock
0.05
+62.27%
0.03
+28.78%
0.02
+47.56%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
8.33
+62.27%
5.14
+28.78%
3.99
+47.56%
2.70
Ordinary Shares Number
8.33
+62.27%
5.14
+28.78%
3.99
+47.56%
2.70
Additional Paid In Capital
85.63
+12.98%
75.80
+9.99%
68.91
+14.06%
60.41
Retained Earnings
-78.61
-4.81%
-75.00
-19.65%
-62.69
-23.33%
-50.83
Total Equity Gross Minority Interest
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Total Capitalization
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Working Capital
7.92
+227.72%
2.42
-56.20%
5.52
-39.18%
9.08
Invested Capital
7.07
+760.39%
0.82
-86.85%
6.25
-34.93%
9.60
Total Debt
0.27
+2.55%
0.26
+41.08%
0.18
-9.12%
0.20
Capital Lease Obligations
0.27
+2.55%
0.26
+41.08%
0.18
-9.12%
0.20
Net Tangible Assets
7.03
+831.11%
0.75
-87.75%
6.16
-35.11%
9.49
Tangible Book Value
7.03
+831.11%
0.75
-87.75%
6.16
-35.11%
9.49
Derivative Product Liabilities
1.27
-40.81%
2.14
0.00
—
Other Inventories
0.87
-0.64%
0.88
-27.08%
1.20
+200.65%
0.40
Line Item Trend 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Cash Flow
-2.84
+74.23%
-11.01
+14.55%
-12.89
-71.38%
-7.52
Cash Flow From Continuing Operating Activities
-2.84
+74.23%
-11.01
+14.55%
-12.89
-71.38%
-7.52
Net Income From Continuing Operations
-3.61
+70.73%
-12.32
-3.87%
-11.86
-18.60%
-10.00
Depreciation Amortization Depletion
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
Depreciation
0.24
+6.63%
0.22
+26.86%
0.18
+83.74%
0.10
Amortization Cash Flow
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Depreciation And Amortization
0.26
+6.03%
0.25
+23.85%
0.20
+67.99%
0.12
Amortization Of Intangibles
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Other Non Cash Items
-0.34
-150.63%
0.67
+509.67%
0.11
-48.23%
0.21
Stock Based Compensation
1.26
-5.94%
1.34
+21.62%
1.11
+16.71%
0.95
Provisionand Write Offof Assets
0.01
0.00
—
—
Operating Gains Losses
—
—
0.03
—
Gain Loss On Investment Securities
—
—
—
—
Gain Loss On Sale Of PPE
—
0.00
-100.00%
0.03
0.00
Change In Working Capital
-0.43
+55.04%
-0.95
+60.69%
-2.43
-300.11%
1.21
Change In Receivables
-1.09
-516.05%
-0.18
-631.44%
0.03
+120.13%
0.02
Changes In Account Receivables
-1.09
-516.05%
-0.18
-631.44%
0.03
+120.13%
0.02
Change In Inventory
0.40
+143.85%
-0.91
+11.12%
-1.02
-68.60%
-0.61
Change In Prepaid Assets
0.08
+58.80%
0.05
+43.71%
0.03
+122.61%
-0.15
Change In Payables And Accrued Expense
0.19
+122.99%
0.08
+105.65%
-1.47
-175.50%
1.95
Change In Accrued Expense
-0.05
-435.77%
0.02
+101.32%
-1.23
-185.40%
1.43
Change In Payable
0.24
+258.22%
0.07
+127.10%
-0.25
-147.96%
0.52
Change In Account Payable
0.24
+258.22%
0.07
+127.10%
-0.25
-147.96%
0.52
Investing Cash Flow
-0.08
+31.99%
-0.12
-104.54%
2.65
+181.67%
-3.24
Cash Flow From Continuing Investing Activities
-0.08
+31.99%
-0.12
-104.54%
2.65
+181.67%
-3.24
Net PPE Purchase And Sale
-0.08
+31.99%
-0.12
+68.09%
-0.38
-36.84%
-0.28
Purchase Of PPE
-0.08
+31.99%
-0.12
+68.71%
-0.38
-39.56%
-0.28
Sale Of PPE
—
0.00
-100.00%
0.01
0.00
Capital Expenditure
-0.08
+31.99%
-0.12
+68.71%
-0.38
-39.56%
-0.28
Net Investment Purchase And Sale
—
0.00
-100.00%
3.03
+201.92%
-2.97
Purchase Of Investment
—
0.00
+100.00%
-1.47
+57.53%
-3.47
Sale Of Investment
—
0.00
-100.00%
4.50
+800.00%
0.50
Financing Cash Flow
8.03
+10.45%
7.27
-1.75%
7.40
-38.46%
12.02
Cash Flow From Continuing Financing Activities
8.03
+10.45%
7.27
-1.75%
7.40
-38.46%
12.02
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
9.49
+63.91%
5.79
-31.66%
8.47
-36.55%
13.35
Common Stock Payments
-0.12
-53.09%
-0.08
+31.83%
-0.12
0.00
Repurchase Of Capital Stock
-0.12
-53.09%
-0.08
+31.83%
-0.12
0.00
Proceeds From Stock Option Exercised
0.07
-96.15%
1.81
0.00
0.00
Net Other Financing Charges
-1.53
-359.52%
-0.33
+68.93%
-1.07
+19.26%
-1.33
Changes In Cash
5.11
+232.31%
-3.86
-36.11%
-2.84
-325.41%
1.26
Beginning Cash Position
1.46
-72.57%
5.32
-34.78%
8.16
+18.24%
6.90
End Cash Position
6.57
+350.01%
1.46
-72.57%
5.32
-34.78%
8.16
Free Cash Flow
-2.92
+73.78%
-11.13
+16.12%
-13.27
-70.26%
-7.79
Amortization Of Securities
—
0.00
+100.00%
-0.05
-297.27%
-0.01
Common Stock Issuance
9.61
+63.76%
5.87
-31.66%
8.59
-35.66%
13.35
Issuance Of Capital Stock
9.61
+63.76%
5.87
-31.66%
8.59
-35.66%
13.35
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category